Antimicrobial Resistance Profile of Different Clinical Isolates against Third-Generation Cephalosporins

Table 4

Resistance pattern of the different clinical isolates to ceftazidime.

Clinical isolates	Resistance pattern
	Resistant	Intermediate	Susceptible	Total
E. coli	41 (65.1%)	10 (15.9%)	12 (19.0%)	63
Citrobacter species	29 (56.9%)	8 (15.7%)	14 (27.4%)	51
S. aureus	16 (34.0%)	20 (42.6%)	11 (23.4%)	47
Enterobacter species	35 (79.6%)	6 (13.6%)	3(6.8%)	44
K. pneumonia	19 (73.1%)	5 (19.2%)	2 (7.7%)	26
K. oxytoca	4 (80%)	2 (20%)	0	6
Y. enterocolitica	2 (33.3%)	0	4 (66.7%)	6
Proteus species	3 (60.0%)	2 (40.0%)	0	5
Total	149 (60.1%)	53 (21.4%)	46 (18.5%)	248 (100)